Portugal

Fri
13
Sep

Germany receives first medical cannabis imports from Portugal and Australia

Germany received its first imports of medicinal cannabis from Portugal and Australia this week. Two German companies took delivery of the shipments that will be used for testing purposes and to supply the country’s growing demand for medical marijuana, which was legalized in 2017.

In Cologne, Cannamedical Pharma received a commercial shipment of cannabis from a company in Portugal. Although the company did not identify the shipper, last month Tilray Portugal announced that it had come to an agreement with Cannamedical to export medicinal cannabis to Germany.

Fri
06
Sep

Another Canadian Company sets up Portuguese growing operation

Portugal’s California-like weather has seen a third Canadian company look to establish a cannabis cultivation footprint in the country.

First it was Tilray, then it was Aurora and now The Flowr Corporation is set to grow cannabis in the country. Flowr has announced plans to acquire the remaining 80% stake in Portuguese firm Holigen which has established a huge cannabis operation in Aljustrel, about 100 miles south east of the capital Lisbon.

Thu
22
Aug

Germany orders 3 million euros of cannabis from Tilray Portugal

The Canadian company, which opened its medical cannabis production plant in Cantanhede in the Coimbra district this year, and recently leased 20 hectares of production land in Reguengos de Monsaraz, near Évora, has signed an initial supply contract of 3.3 million dollars (approximately three million euros) with Cannamedical Pharma to increase the distribution of medical cannabis products to German patients.

The export operation is expected to be carried out in the autumn, being "the first of its kind that Tilray will conduct from its Portugal facility to supply patients in Germany," the company explained.

Wed
21
Aug

Tilray signs first deal to supply pot to Europe out of new Portugal facility

Tilray Inc. has signed its first agreement to supply a European Union country with cannabis from its recently opened facility in Portugal, the company announced early Wednesday morning.

The freshly inked contract with Cannamedical Pharma GmbH to export $3.3 million worth of cannabis to medical patients in Germany gives Tilray TLRY, +3.45%  access to a country with a population and gross domestic product that are twice the size of its home country, Canada. The deal also marks another step for Tilray and its global ambitions, Chief Executive Brendan Kennedy said in a telephone interview.

Wed
07
Aug

Tilray® increases international export capacity with new outdoor cultivation site in Portugal

Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda.

Tue
30
Jul

Flowr Ships clones to support start-up of operations in Portugal

The Flowr Corporation (TSXV: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announce that Holigen Holdings Limited (“Holigen”), which Flowr is in the process of acquiring the remaining 80.2% interest, subject to regulatory approval, has through its subsidiary RPK Biopharma, Unipessoal Lda, received permission from INFARMED to plant cannabis at the Aljustrel project in Portugal.

Mon
08
Jul

Tilray speeds expansion in Europe

Tilray Inc. is expanding its European leadership team and setting up a hub in Portugal, deepening its planned international reach.

The company appointed five senior members to its European team, according to a statement Friday. Arne Wilkens, a former executive at the German pharmaceuticals company AiCuris, will take on the role of vice president of business expansion in Europe.

Wed
05
Jun

Hemp farmers in Portugal say 2019 growing season is lost

Some Portuguese hemp farmers say they’ll give up on the 2019 growing season due to continuing jurisdictional confusion between two government agencies over licensing.

The problem started when Portugal’s Ministry of Agriculture issued a clarification in January 2019 making all hemp related authorizations subject to review by INFARMED, the Portuguese Health Regulator that has authority over pharmaceutical products and controlled substances.

Tue
21
May

A brief history of CBD

CBD – short for Cannabidiol – is a compound inside hemp and cannabis that was first discovered in 1940. Recent studies have shown CBD to have medicinal value for treating things like anxiety, pain, and insomnia but where did the story begin with this gift from nature?

Fri
03
May

Portugal: €45M investment in medical marijuana production

Holigen have announced plans to invest €45 million in the production of medical marijuana in Portugal over the next four years.

Pauric Duffy from Holigen told Lusa News Agency that he expects the investment will lead to the creation of some 200 jobs.

"We received our production license this year and we are building our facilities in Sintra (21,500 square metres) and Aljustrel (7,000,000 square metres). If the entire licensing process goes as planned, in the third quarter of 2019 we will be fully operational in Sintra and, in 2020, in Aljustrel”, said Duffy.

Pages

Subscribe to RSS - Portugal